Stay updated with breaking news from Nasdaq Ortx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orchard Therapeutics (NASDAQ:ORTX – Get Free Report) and MiNK Therapeutics (NASDAQ:INKT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends. Volatility & Risk Orchard Therapeutics has a […]
Oppenheimer restated their outperform rating on shares of Orchard Therapeutics (NASDAQ:ORTX – Free Report) in a research report released on Wednesday morning, Benzinga reports. They currently have a $34.00 target price on the stock. Separately, Cantor Fitzgerald restated an overweight rating on shares of Orchard Therapeutics in a report on Monday, May 15th. Get Our […]
BOSTON and LONDON, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, expresses its strong appreciation...
Orchard Therapeutics (NASDAQ:ORTX – Get Free Report) and Peak Bio (NASDAQ:PKBO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership. Earnings & Valuation This table compares Orchard […]
Orchard Therapeutics plc (NASDAQ:ORTX – Get Free Report) shares were up 0.4% during mid-day trading on Tuesday . The company traded as high as $5.20 and last traded at $5.11. Approximately 13,587 shares changed hands during trading, a decline of 83% from the average daily volume of 78,334 shares. The stock had previously closed at […]